Vimarsana
Biggest News Aggregation in the World

Page 7 - Jonathan Silverberg News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Jonathan Silverberg. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Jonathan Silverberg Today - Breaking & Trending Today

Upadacitinib 30 mg Tops Atopic Dermatitis Systemic Therapies in Meta-Analyses - Vimarsana News

Upadacitinib 30 mg Tops Atopic Dermatitis Systemic Therapies in Meta-Analyses

Updated analysis of more than a dozen clinical trials assessing monotherapy systemic treatment of atopic dermatitis shows upadacitinib's highly prevalent efficacy in clearing skin.

Revolutionizing Atopic Dermatitis Conference Promises New Ways to Learn About AD - Vimarsana News

Revolutionizing Atopic Dermatitis Conference Promises New Ways to Learn About AD

The Revolutionizing Atopic Dermatitis conference, set to begin on April 29 in Washington, DC, promises to offer symposia on emerging therapies and new insights into treating atopic dermatitis (AD).

Source: ajmc.com
Almirall: The New England Journal of Medicine (NEJM) and the British Journal of Dermatology (BJD) publish Ph3 data evaluating lebrikizumab efficacy and safety in moderate-to-severe atopic dermatitis - Vimarsana News

Almirall: The New England Journal of Medicine (NEJM) and the British Journal of Dermatology (BJD) publish Ph3 data evaluating lebrikizumab efficacy and safety in moderate-to-severe atopic dermatitis

Almirall, S.A. (ALM), a global biopharmaceutical company focused on medical dermatology, announced today the publication of Week 16 and Week 52 results of ADvocate1 and ADvocate2 by the New England Journal of Medicine (NEJM) and the British Journal of Dermatology (BJD), respectively. ADvocate1 and ADvocate2 are two ...

New Drug Could Be Treatment Option for People With Eczema - Vimarsana News

New Drug Could Be Treatment Option for People With Eczema

MONDAY, March 20, 2023 (HealthDay News) -- Patients could soon have access to a new injectable drug to treat atopic dermatitis, the most common form of eczema.

Source: kulr8.com
Injectable drug lebrikizumab may soon be available to treat eczema - Vimarsana News

Injectable drug lebrikizumab may soon be available to treat eczema

Patients could soon have access to a new injectable drug to treat atopic dermatitis, the most common form of eczema.

Source: upi.com